Cost of lipitor
Pro Research Analysisby 
Searched over 200M research papers
Cost of Lipitor: An Analysis
Average Cost of Lipitor in Wayne County, Michigan
A study conducted in Wayne County, Michigan, examined the out-of-pocket costs for various medications, including Lipitor (atorvastatin). The research found that the average cost for a 30-day supply of brand-name Lipitor (20 mg) was approximately $140.45 ± $14.70 across different ZIP codes in the county. This study highlighted that the cost of Lipitor did not vary significantly based on ZIP code characteristics such as household income or racial demographics.
National Expenditures on Lipitor Post-Generic Introduction
Despite the availability of generic atorvastatin since November 2011, the national healthcare expenditures associated with the continued use of brand-name Lipitor have been substantial. An analysis of data from the Medical Expenditures Panel Survey (2012-2014) estimated that there were significant excess costs incurred due to the preference for Lipitor over its generic counterparts. This indicates that even after the introduction of generic options, many patients and healthcare providers continued to opt for the brand-name drug, leading to higher overall healthcare costs.
Impact of Pfizer's Strategies on Lipitor Costs
Pfizer implemented several strategies to maintain the market presence of Lipitor following the loss of its market exclusivity. These strategies included agreements with health plans and pharmacy benefit managers, as well as the "Lipitor for You" program, which aimed to offer Lipitor at competitive prices comparable to generics during the initial 180-day period post-exclusivity. These efforts were intended to enhance competition and provide patients with access to the branded medication at lower costs. However, the long-term impact of these strategies on the overall cost dynamics in the atorvastatin market remains a subject of discussion.
Conclusion
The cost of Lipitor varies by region, with an average price of around $140.45 for a 30-day supply in Wayne County, Michigan. Nationally, the continued use of brand-name Lipitor after the introduction of generic atorvastatin has led to significant excess healthcare expenditures. Pfizer's initiatives to keep Lipitor competitively priced post-exclusivity have influenced market dynamics, but the broader implications on cost savings and generic competition are complex. Understanding these factors is crucial for making informed decisions about medication costs and healthcare spending.
Sources and full results
Most relevant research papers on this topic